Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Observation × Thoracic × Clear all

Status

Recruiting 6 Active not recruiting 6 Completed 5 Not yet recruiting 4 Withdrawn 1 Unknown 1 Terminated 1 Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 4 Gastrointestinal 4 Breast 3 Sarcoma 2 Gynecologic 2 Thoracic 1 Other neoplasm 1 Other hematologic neoplasm 1 Other 1 Myeloid 1 Lymphoid 1 Head & Neck 1 Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 123 Pemetrexed 108 Cisplatin 93 pembrolizumab 79 Docetaxel 78 Paclitaxel 74 Erlotinib Hydrochloride 51 Radiotherapy 50 Gemcitabine 44 Nivolumab 43 Bevacizumab 35 Etoposide 32 Radiosurgery 28 atezolizumab 26 durvalumab 21 Cyclophosphamide 20 Vinorelbine 18 Radiation 15 Ipilimumab 15 Albumin-Bound Paclitaxel 14 Taxes 13 Irinotecan 12 Gefitinib 12 Drug Therapy 12 130-nm albumin-bound paclitaxel 12 Magnetic Resonance Spectroscopy 11 Dexamethasone 11 osimertinib 10 avelumab 10 Cetuximab 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05032352 2022-11-14

PADMA

Insight Molecular Diagnostics

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡